Thank you and good morning everyone. Matt McKee and I appreciate you joining us today. We released our second quarter results this morning and plan on filing our 10-Q by the end of the week. Today, in my opening remarks, I'll first discuss our Q2 financial highlights and key accomplishments. I'll then share our perspective on the latest industry trends and developments, and then lastly I'll provide an update on our second half of the year priorities and outlook for the rest of the year. I'll then turn the call over to Matt to provide a more detailed discussion on the quarter. So with that overview, I'd like to now discuss our Q2 financial highlights and key accomplishments. For the three months ended June 30, 2024, we reported revenue of $426.3 million in line with expectations, net loss and diluted loss per share of $1.8 million and $0.02, which includes the $0.22 impact of client restructuring charges and reported cash flow from operations of $16.3 million and adjusted cash flow used in operations of $2.4 million. Our field-based team delivered strong service execution leading to another successful quarter of managing cost of services, excluding CECL within our targeted range. Additionally, we achieved over 96% cash collections during the quarter, which fell short of our Q2 target but showed improvement compared to last quarter and the same period last year, and importantly keeps us on track to meet our 2024 adjusted cash flow objectives. We highlighted this issue last quarter, but the majority of our customers affected by the February Change Healthcare cyberattack applied for CMS' accelerated and advanced payments program and expected that supplemental funding in late April to early May. Unfortunately, many of those affected clients encountered delays in receiving that supplemental funding. As of today, we are confident that all of our affected customers that applied have received their supplemental funding, and we expect to make up the $12 million to $15 million change healthcare related delay in cash collection in the back half of the year, which is why we're reaffirming our 2024 adjusted cash flow range of $40 million to $55 million. Our second quarter results also include the impact of the previously announced LaVie Care Centers' Chapter 11 filing. The recent restructuring activity we've seen, including LaVie’s, is the result of conditions and events that occurred over the course of the past few years, as opposed to a reflection of the sector's current state. And while this restructuring impacts our second quarter results, longer term, it only further strengthens the financial health of our customer base. I'd now like to share our perspective on the latest industry trends and developments. Industry fundamentals continue to trend positively, highlighted by a slow but steady increase in workforce availability, with the industry adding over 100,000 jobs since the beginning of 2023 rising occupancy, which now sits at 79.3%, 12 points higher than the January 2021 low, and just 1% under pre-pandemic levels and a stable reimbursement environment, which includes CMS' proposed 4.1% increase in Medicare rates for fiscal year 2025, as well as continued, positive reimbursement trends at the state level. On the regulatory front, we continue to believe CMS' final minimum staffing rule will either undergo significant revision during the extended phase in period or will not be implemented, especially given the pending litigation and the potential for legislation or administration change. Specifically as it relates to the pending litigation, the American Health Care Association, the Texas Healthcare association and three Texas SNFs, filed a lawsuit in the Northern District of Texas on May 23. They are represented by a former U.S. solicitor general, Paul Clement, arguably today's top constitutional and Supreme Court lawyer. ACCA and the other lead plaintiffs believe the arguments of their case are very strong on the merits and even further bolstered by, SCOTUS’ recent ruling that overturned the Chevron doctrine. As we head into the second half of the year, our three strategic priorities remain unchanged. First is continuing to manage cost of services within our 86% targeted range, building on the operational momentum achieved in the second quarter. Second, is driving growth. We are raising our Q3 and Q4 revenue estimates to $425 million to $435 million and $430 million to $440 million, respectively, to reflect our second half of year top line expectations. Third is collecting what we bill. We expect cash collections to continue to gain strength over the next six months and further still into 2025 and reaffirm our 2024 adjusted cash flow forecast of $40 million to $55 million. I would like to elaborate on our second priority, driving growth. The past five years have presented unprecedented challenges to our industry, including a record number of ownership changes, the operational and clinical disruptions of COVID-19, a significant workforce exodus, depressed occupancy levels and rapid wage inflation. Clearly, these were not ideal conditions to expand our footprint. However, our dedicated team members have persevered and the industry is steadily rebounding. Sector occupancy is approaching pre-pandemic levels and we have growing confidence in our ability to assess the financial stability of potential customers. Most importantly, our value proposition for both existing and new clients has never been stronger, which positions us perfectly to capitalize on the multi-decade secular tailwind that will benefit the sector for years to come. This is truly an exciting time for our organization as we shift our focus back to growth. We are confident that by leveraging our talent, reputation and value proposition, we will deliver on our commitment to our existing customers while capitalizing on the abundant new opportunities we've identified to achieve top line growth. We are eager to share our progress with you in the coming quarters and years. So in closing, our strong business fundamentals and strategic priorities position us to boost profitability, growth and cash flow in the second half of the year, and we remain confident in our ability to deliver meaningful long-term shareholder value. So with those introductory comments, I'll turn the call over to Matt for a more detailed discussion on the quarter.